A
Amanda K. Leonberg-Yoo
Researcher at University of Pennsylvania
Publications - 28
Citations - 1765
Amanda K. Leonberg-Yoo is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Population & Kidney disease. The author has an hindex of 8, co-authored 27 publications receiving 841 citations. Previous affiliations of Amanda K. Leonberg-Yoo include Hospital of the University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Shruti Gupta,Salim S. Hayek,Wei Wang,Lili Chan,Kusum S. Mathews,Michal L. Melamed,Samantha K. Brenner,Amanda K. Leonberg-Yoo,Edward J. Schenck,Jared Radbel,Jochen Reiser,Anip Bansal,Anand Srivastava,Yan Zhou,Anne Sutherland,Adam E. Green,Alexandre M. Shehata,Nitender Goyal,Anitha Vijayan,Juan Carlos Q. Velez,Juan Carlos Q. Velez,Shahzad Shaefi,Chirag R. Parikh,Justin Arunthamakun,Ambarish M. Athavale,Allon N. Friedman,Samuel A.P. Short,Zoe A. Kibbelaar,Samah Abu Omar,Andrew J Admon,John P. Donnelly,Hayley B. Gershengorn,Hayley B. Gershengorn,Miguel A. Hernán,Miguel A. Hernán,Matthew W. Semler,David E. Leaf +36 more
TL;DR: This study identified demographic, clinical, and hospital-level risk factors that may be associated with death in critically ill patients with COVID-19 and can facilitate the identification of medications and supportive therapies to improve outcomes.
Journal ArticleDOI
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
Shruti Gupta,Wei Wang,Salim S. Hayek,Lili Chan,Kusum S. Mathews,Michal L. Melamed,Samantha K. Brenner,Samantha K. Brenner,Amanda K. Leonberg-Yoo,Edward J. Schenck,Jared Radbel,Jochen Reiser,Anip Bansal,Anand Srivastava,Yan Zhou,Diana Finkel,Adam E. Green,Mary Mallappallil,Anthony J. Faugno,Jingjing Zhang,Juan Carlos Q. Velez,Juan Carlos Q. Velez,Shahzad Shaefi,Chirag R. Parikh,David M. Charytan,Ambarish M. Athavale,Allon N. Friedman,Roberta E. Redfern,Samuel A.P. Short,Simon Correa,Kapil K. Pokharel,Andrew J Admon,John P. Donnelly,Hayley B. Gershengorn,Hayley B. Gershengorn,David J. Douin,Matthew W. Semler,Miguel A. Hernán,David E. Leaf +38 more
TL;DR: Among critically ill patients with COVID-19 in this cohort study, the risk of in-hospital mortality in this study was lower in patients treated with tocilizumab in the first 2 days of ICU admission compared with patients whose treatment did not include early use of tocilzumab, and the findings may be susceptible to unmeasured confounding.
Journal ArticleDOI
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catherine M. Clase,Juan Jesus Carrero,David H. Ellison,Morgan E. Grams,Brenda R. Hemmelgarn,Meg Jardine,Meg Jardine,Csaba P. Kovesdy,Csaba P. Kovesdy,Gregory A. Kline,Gregor Lindner,Gregorio T. Obrador,Biff F. Palmer,Michael Cheung,David C. Wheeler,Wolfgang C. Winkelmayer,Roberto Pecoits-Filho,Gloria Ashuntantang,Stephan J. L. Bakker,George L. Bakris,Sunil Bhandari,Emmanuel A. Burdmann,Katrina L. Campbell,David M. Charytan,Deborah J. Clegg,Lilian Cuppari,David Goldsmith,Stein Hallan,Jiang He,Charles A. Herzog,Melanie P. Hoenig,Ewout J. Hoorn,Jens Leipziger,Amanda K. Leonberg-Yoo,Edgar V. Lerma,Jose Ernesto Lopez-Almaraz,Jolanta Malyszko,Johannes F.E. Mann,Matti Marklund,Alicia A. McDonough,Masahiko Nagahama,Sankar D. Navaneethan,Bertram Pitt,Oleh Pochynyuk,Thyago Proença de Moraes,Zubaid Rafique,Bruce M. Robinson,Simon D. Roger,Patrick Rossignol,Adam J. Singer,Andrew Smyth,Manish M. Sood,Michael Walsh,Matthew R. Weir,Charles S. Wingo +54 more
TL;DR: Conference deliberations on potassium homeostasis in health and disease, guidance for evaluation and management of dyskalemias in the context of kidney diseases, and research priorities in each of the above areas are provided.
Journal ArticleDOI
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19.
Shahzad Shaefi,Samantha K Brenner,Shruti Gupta,Brian O’Gara,Megan L. Krajewski,David M. Charytan,Sobaata Chaudhry,Sara Mirza,Vasil Peev,Mark E. Anderson,Anip Bansal,Salim S. Hayek,Anand Srivastava,Kusum S. Mathews,Tanya S. Johns,Amanda K. Leonberg-Yoo,Adam E. Green,Justin Arunthamakun,Keith M. Wille,Tanveer Shaukat,Harkarandeep Singh,Andrew J Admon,Matthew W. Semler,Miguel A. Hernán,Miguel A. Hernán,Ariel Mueller,Wei Wang,David E. Leaf,Stop-Covid Investigators +28 more
TL;DR: In this article, the authors examined the clinical features and outcomes of 190 patients treated with ECMO within 14 days of ICU admission, using data from a multicenter cohort study of 5122 critically ill adults with COVID-19 admitted to 68 hospitals across the United States.
Journal ArticleDOI
The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?
Michael R. Rudnick,Amanda K. Leonberg-Yoo,Harold Litt,Raphael M. Cohen,Susan Hilton,Peter P. Reese +5 more
TL;DR: Patients at any increased risk for CIN needs to be balanced by the risk of not performing an intravenous contrast-enhanced study, which would further increase the risk.